PERSISTENT EFFECTS OF (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY) ON HUMAN SLEEP

被引:89
|
作者
ALLEN, RP
MCCANN, UD
RICAURTE, GA
机构
[1] NIMH, BIOL PSYCHIAT BRANCH, ANXIETY & AFFECT DISORDERS SECT, BLDG 10, BETHESDA, MD 20892 USA
[2] JOHNS HOPKINS UNIV, SCH MED, FRANCIS SCOTT KEY MED CTR, DEPT NEUROL, BALTIMORE, MD 21205 USA
来源
SLEEP | 1993年 / 16卷 / 06期
关键词
MDMA; SEROTONIN; NEUROTOXICITY; AMPHETAMINES; SLEEP;
D O I
10.1093/sleep/16.6.560
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
(+/-)3,4-methylenedioxymethamphetamine (MDMA) is a recreational drug of abuse which damages serotonin neurons in animals. It is not known whether MDMA is also neurotoxic in humans, and if so, whether there are functional consequences. Given the putative role of serotonin in sleep, it was hypothesized that one manifestation of serotonin neurotoxicity in humans might be disturbances of sleep. To determine whether MDMA use has effects on sleep, all-night polysomnograms of 23 MDMA users were compared to those of 22 age- and sex-matched controls. On average, MDMA users had 19 minutes less total sleep and 23.2 minutes less non-REM (NREM) sleep than controls. These statistically significant differences in NREM sleep were due primarily to an average of 37 minutes less stage 2 sleep, with no significant differences noted in stages 1, 3 or 4. Although it is not known whether the alterations in sleep observed in MDMA users are due to serotonin neurotoxicity, the present findings suggest that MDMA use can lead to persistent changes in CNS structures involved in human sleep generation.
引用
收藏
页码:560 / 564
页数:5
相关论文
共 50 条
  • [1] Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA)
    Morimoto, BH
    Lovell, S
    Kahr, B
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1998, 54 : 229 - 231
  • [2] The cardiovascular effects of ecstasy (3,4-methylenedioxymethamphetamine, MDMA)
    Lester, SJ
    Baggott, MJ
    Viloria, EM
    Welm, S
    Schiller, NB
    Mendelson, J
    Jones, RT
    Foster, E
    CIRCULATION, 1999, 100 (18) : 575 - 575
  • [3] The Agony of Ecstasy: MDMA (3,4-Methylenedioxymethamphetamine) and the Kidney
    Campbell, Garland A.
    Rosner, Mitchell H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (06): : 1852 - 1860
  • [4] NEUROCHEMISTRY AND NEUROTOXICITY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY)
    MCKENNA, DJ
    PEROUTKA, SJ
    JOURNAL OF NEUROCHEMISTRY, 1990, 54 (01) : 14 - 22
  • [5] Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy')
    McCann, UD
    Slate, SO
    Ricaurte, GA
    DRUG SAFETY, 1996, 15 (02) : 107 - 115
  • [6] 3,4-methylenedioxymethamphetamine (MDMA, or ''ecstasy'') and associated hypoglycemia
    Montgomery, H
    Myerson, S
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1997, 15 (02): : 218 - 218
  • [7] 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment
    Logan, BK
    Couper, FJ
    JOURNAL OF FORENSIC SCIENCES, 2001, 46 (06) : 1426 - 1433
  • [8] Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users
    Back-Madruga, C
    Boone, KB
    Chang, L
    Grob, CS
    Lee, A
    Nations, H
    Poland, RE
    CLINICAL NEUROPSYCHOLOGIST, 2003, 17 (04) : 446 - 459
  • [9] Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?
    Allott, Kelly
    Redman, Jennifer
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2007, 31 (03): : 327 - 347
  • [10] Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users
    Back-Madruga, C
    Boone, K
    Chang, L
    Grob, C
    Poland, R
    Lee, A
    Nations, H
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2003, 18 (07) : 720 - 720